Efforts to prevent or delay type 1 diabetes have traditionally focused on the autoimmune attack that destroys insulin-producing beta cells. However, emerging research suggests metabolic stress may also influence how quickly vulnerable people progress to clinical disease. A 2026 TrialNet analysis found that autoantibody-positive people with overweight or obesity who …
Read More »Could a Virus Vaccine Help Prevent Type 1 Diabetes? Inside the Human Trials
Could preventing a common viral infection also prevent some cases of type 1 diabetes? Researchers have pursued that question for decades, and the first human vaccine studies are providing important clues. The idea of using a Coxsackievirus vaccine to help prevent type 1 diabetes focuses on certain Coxsackie B viruses, …
Read More »Why Scientists Are Taking Another Look at the BCG Vaccine for Type 1 Diabetes
For more than 100 years, the Bacillus Calmette-Guérin (BCG) vaccine has been used worldwide to help prevent tuberculosis. However, researchers are now exploring another possible role for this familiar vaccine. Recent studies suggest that the BCG vaccine may play a role in treating type 1 diabetes by modifying the immune …
Read More »Could Too Much Protein Be Affecting Insulin? Scientists Take a Closer Look
New research is changing the conversation around protein and metabolic health. For years, high-protein diets have been praised for supporting weight loss, preserving muscle, and improving blood sugar control. However, scientists are now discovering that the story may be more complex. Rather than blaming protein itself, researchers are focusing on …
Read More »Could a Mini Pancreas Predict Which Diabetes Drug Will Work Best?
Finding the right diabetes medication often involves trial and error. One patient may respond well to a GLP-1 receptor agonist, while another sees little benefit from the same treatment. As a result, clinicians frequently adjust medications before finding the most effective option. What if doctors could test a patient’s response …
Read More »Amylin Is Making a Comeback: Why This Forgotten Hormone Is Back in the Spotlight
For years, glucagon-like peptide-1 (GLP-1) receptor agonists have dominated conversations about diabetes and obesity treatment. However, another hormone is quietly returning to the spotlight. Amylin diabetes therapy is making a comeback as researchers develop a new generation of drugs designed to improve blood glucose control and support weight management. Amylin …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.